BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 36200802)

  • 1. Shrunken pore syndrome in childhood cancer survivors treated with potentially nephrotoxic therapy.
    Kooijmans ECM; van der Pal HJH; Pilon MCF; Pluijm SMF; van der Heiden-van der Loo M; Kremer LCM; Bresters D; van Dulmen-den Broeder E; van den Heuvel-Eibrink MM; Loonen JJ; Louwerens M; Neggers SJC; van Santen HM; Tissing WJE; de Vries ACH; Kaspers GJL; Veening MA; Bökenkamp A;
    Scand J Clin Lab Invest; 2022; 82(7-8):541-548. PubMed ID: 36200802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Estimated Glomerular Filtration Rate with Both Serum Creatinine and Cystatin C (eGFRcr-cys) versus Single Analyte (eGFRcr or eGFRcys) Using CKD-EPI and MDRD Equations in Tertiary Care Hospital Settings.
    Khalid UB; Haroon ZH; Aamir M; Ain QU; Mansoor K; Jaffar SR
    J Coll Physicians Surg Pak; 2020 Jul; 30(7):701-706. PubMed ID: 32811598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypertension in long-term childhood cancer survivors after treatment with potentially nephrotoxic therapy; DCCSS-LATER 2: Renal study.
    Kooijmans ECM; van der Pal HJH; Pluijm SMF; Bresters D; van Dulmen-den Broeder E; van der Heiden-van der Loo M; van den Heuvel-Eibrink MM; Kremer LCM; Loonen JJ; Louwerens M; Neggers SJC; Pilon M; Ronckers C; Tissing WJE; de Vries ACH; Kaspers GJL; Bökenkamp A; Veening MA;
    Eur J Cancer; 2022 Sep; 172():287-299. PubMed ID: 35810554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Dutch Childhood Cancer Survivor Study (DCCSS)-LATER 2 kidney analysis examined long-term glomerular dysfunction in childhood cancer survivors.
    Kooijmans ECM; van der Pal HJH; Pluijm SMF; van der Heiden-van der Loo M; Kremer LCM; Bresters D; van Dulmen-den Broeder E; van den Heuvel-Eibrink MM; Loonen JJ; Louwerens M; Neggers SJC; Ronckers C; Tissing WJE; de Vries ACH; Kaspers GJL; Veening MA; Bökenkamp A;
    Kidney Int; 2022 Nov; 102(5):1136-1146. PubMed ID: 35772499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early and late adverse renal effects after potentially nephrotoxic treatment for childhood cancer.
    Kooijmans EC; Bökenkamp A; Tjahjadi NS; Tettero JM; van Dulmen-den Broeder E; van der Pal HJ; Veening MA
    Cochrane Database Syst Rev; 2019 Mar; 3(3):CD008944. PubMed ID: 30855726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Shrunken Pore Syndrome is associated with a sharp rise in mortality in patients undergoing elective coronary artery bypass grafting.
    Dardashti A; Nozohoor S; Grubb A; Bjursten H
    Scand J Clin Lab Invest; 2016; 76(1):74-81. PubMed ID: 26647957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early and late renal adverse effects after potentially nephrotoxic treatment for childhood cancer.
    Knijnenburg SL; Mulder RL; Schouten-Van Meeteren AY; Bökenkamp A; Blufpand H; van Dulmen-den Broeder E; Veening MA; Kremer LC; Jaspers MW
    Cochrane Database Syst Rev; 2013 Oct; (10):CD008944. PubMed ID: 24101439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance of cystatin C- and creatinine-based estimated glomerular filtration rate equations depends on patient characteristics.
    Meeusen JW; Rule AD; Voskoboev N; Baumann NA; Lieske JC
    Clin Chem; 2015 Oct; 61(10):1265-72. PubMed ID: 26240296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Shrunken pore syndrome and mortality: a cohort study of patients with measured GFR and known comorbidities.
    Åkesson A; Lindström V; Nyman U; Jonsson M; Abrahamson M; Christensson A; Björk J; Grubb A
    Scand J Clin Lab Invest; 2020 Sep; 80(5):412-422. PubMed ID: 32459111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for shrunken pore syndrome in children.
    den Bakker E; Gemke RJ; van Wijk JA; Hubeek I; Stoffel-Wagner B; Bökenkamp A
    Scand J Clin Lab Invest; 2020 Feb; 80(1):32-38. PubMed ID: 31755786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparing GFR Estimating Equations Using Cystatin C and Creatinine in Elderly Individuals.
    Fan L; Levey AS; Gudnason V; Eiriksdottir G; Andresdottir MB; Gudmundsdottir H; Indridason OS; Palsson R; Mitchell G; Inker LA
    J Am Soc Nephrol; 2015 Aug; 26(8):1982-9. PubMed ID: 25527647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glomerular filtration rate estimation using cystatin C alone or combined with creatinine as a confirmatory test.
    Fan L; Inker LA; Rossert J; Froissart M; Rossing P; Mauer M; Levey AS
    Nephrol Dial Transplant; 2014 Jun; 29(6):1195-203. PubMed ID: 24449101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Shrunken Pore Syndrome: A New and More Powerful Phenotype of Renal Dysfunction Than Chronic Kidney Disease for Predicting Contrast-Associated Acute Kidney Injury.
    Zhang LW; Luo MQ; Xie XW; You ZB; Zeng JL; Lin MQ; Chen LC; Lin KY; Guo YS
    J Am Heart Assoc; 2023 Jan; 12(1):e027980. PubMed ID: 36565177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends in the prevalence of reduced GFR in the United States: a comparison of creatinine- and cystatin C-based estimates.
    Grams ME; Juraschek SP; Selvin E; Foster MC; Inker LA; Eckfeldt JH; Levey AS; Coresh J
    Am J Kidney Dis; 2013 Aug; 62(2):253-60. PubMed ID: 23619125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison between 2017 FAS and 2012 CKD-EPI equations: a multi-center validation study in Chinese adult population.
    Yong Z; Li F; Pei X; Liu X; Song D; Zhang X; Zhao W
    Int Urol Nephrol; 2019 Jan; 51(1):139-146. PubMed ID: 30357600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Applicability of chronic kidney disease epidemiology collaboration equations in a Chinese population.
    Zhang M; Chen Y; Tang L; Zhang J; Liu S; Wang S; Wei R; Zhou J; Cao X; Zhang W; Zhang J; Yang Y; Cai G; Sun X; Chen X
    Nephrol Dial Transplant; 2014 Mar; 29(3):580-6. PubMed ID: 24335503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A more accurate method acquirement by a comparison of the prediction equations for estimating glomerular filtration rate in Chinese patients with obstructive nephropathy.
    Chen M; Xia J; Pei G; Zhang Y; Wu S; Qin Y; Deng Y; Guo S; Guo Y; Xu G; Han M
    BMC Nephrol; 2016 Oct; 17(1):150. PubMed ID: 27756243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of MDRD and the old CKD-EPI equations with the new CKD-EPI equations in kidney transplant patients when glomerular filtration rate is measured with 51Cr-EDTA.
    Borrego Utiel FJ; Ramírez Navarro AM; Esteban de la Rosa R; Bravo Soto JA
    Nefrologia (Engl Ed); 2020; 40(1):53-64. PubMed ID: 31843209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cystatin C- and creatinine-based estimated glomerular filtration rate, vascular disease, and mortality in persons with diabetes in the U.S.
    Tsai CW; Grams ME; Inker LA; Coresh J; Selvin E
    Diabetes Care; 2014 Apr; 37(4):1002-8. PubMed ID: 24271191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combining Cystatin C and Creatinine Yields a Reliable Glomerular Filtration Rate Estimation in Older Adults in Contrast to β-Trace Protein and β2-Microglobulin.
    Werner K; Pihlsgård M; Elmståhl S; Legrand H; Nyman U; Christensson A
    Nephron; 2017; 137(1):29-37. PubMed ID: 28407629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.